Skip to main content
. 2021 Jun 30;12:702785. doi: 10.3389/fimmu.2021.702785

Table 5.

Therapeutic approaches for the development and use of SPM mimetics in cancer treatments.

Disadvantages Advantages
SPMs Native Short half-life Biological activities
Analogs Short half-life Increased Stability
Biological activities
Receptor agonists Small molecules Short half-life Increased Stability
Easy to develop
Biological activities
Monoclonal antibodies Manufacturing costs Long exposure for chronic disease
Easy to develop
Specificity and selectivity